QSAM Biosciences, Inc.
A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.39M | 446.60K | 389.70K | 851.40K | 225.30K |
| Total Receivables | -- | 100.00K | -- | 342.70K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 68.90K | 63.70K | 72.90K | 96.20K | 139.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 250.00K | -- | -- | -- | -- |
| Total Current Assets | 1.71M | 610.30K | 462.60K | 1.29M | 364.60K |
|
|
|||||
| Total Current Assets | 1.71M | 610.30K | 462.60K | 1.29M | 364.60K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.71M | 610.30K | 462.60K | 1.29M | 364.60K |
|
|
|||||
| Total Accounts Payable | 568.50K | 1.20M | 862.80K | 860.80K | 745.00K |
| Total Accrued Expenses | 1.30K | 86.40K | 128.10K | 87.00K | 79.20K |
| Short-term Debt | 7.50K | 7.50K | 7.50K | 7.50K | 7.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 443.70K |
| Total Finance Division Other Current Liabilities | 455.50K | 417.50K | 379.50K | 341.90K | 304.70K |
| Total Other Current Liabilities | 455.50K | 417.50K | 379.50K | 341.90K | 304.70K |
| Total Current Liabilities | 1.03M | 1.71M | 1.38M | 1.30M | 1.58M |
|
|
|||||
| Total Current Liabilities | 1.03M | 1.71M | 1.38M | 1.30M | 1.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 7.50K | 7.50K | 7.50K | 7.50K | 7.50K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.03M | 1.71M | 1.38M | 1.30M | 1.58M |
|
|
|||||
| Common Stock & APIC | 41.67M | 39.22M | 38.28M | 36.53M | 33.43M |
| Retained Earnings | -40.16M | -39.67M | -38.47M | -37.23M | -35.18M |
| Treasury Stock & Other | -1.35M | -1.39M | -1.46M | -35.50K | -187.30K |
| Total Common Equity | 163.10K | -1.84M | -1.65M | -735.30K | -1.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 509.20K | 742.80K | 735.60K | 728.40K | 721.20K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 509.20K | 742.80K | 735.60K | 728.40K | 721.20K |
|
|
|||||
| Total Common Equity | 163.10K | -1.84M | -1.65M | -735.30K | -1.94M |
| Total Preferred Equity | 509.20K | 742.80K | 735.60K | 728.40K | 721.20K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 672.30K | -1.10M | -915.30K | -6.90K | -1.22M |
|
|
|||||
